IMPORTANT DISCLAIMER: Blank Capital Research ("BCR") is a technology platform, not a registered investment advisor or broker-dealer. The algorithmically generated signals, scores, and rankings provided on this site ("God Mode" Signals) are for informational and research purposes only and do not constitute financial advice, investment recommendations, or an offer to sell or solicit an offer to buy any securities.
HYPOTHETICAL PERFORMANCE RESULTS: The "timing scores" and "regime signals" displayed are based on quantitative models. Hypothetical or simulated performance results have certain inherent limitations. Unlike an actual performance record, simulated results do not represent actual trading. Also, since the trades have not actually been executed, the results may have under-or-over compensated for the impact, if any, of certain market factors, such as lack of liquidity.
RISK OF LOSS: Trading in financial markets involves a high degree of risk and may result in the loss of your entire investment. Data provided by third-party sources (Intrinio, Snowflake) is believed to be reliable but is not guaranteed for accuracy or completeness. Past performance is not indicative of future results.
© 2026 Blank Capital Research. All rights reserved. System Version: Aegis V8 (God Mode).
Verdict
Quantitative factor alignment verified for current market regime.
Quant Score
Rank
#439
Positioning
Market Dominance
Manufacturing
Chemicals
$4.0B
Sean D. Keohane
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and Asia Pacific.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Dates updated upon official exchange announcement.
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
X-AXIS: EV/EBITDA (LOWER = CHEAPER) | Y-AXIS: ROE (HIGHER = ELITE) | RED CIRCLE = CBT ANALYSIS TARGET
| Stock | Rating | Score▼ | Quality | Value | Momentum | P/E | EV/EBITDA | ROE | ROA | Gross Mgn | Op Mgn | Net Mgn | Rev Growth | Div Yield | D/E | Mkt Cap | AUDIT |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
$UL UNILEVER PLC | 78 | 96 | 98 | 59 | - | - | 28.5% | 8.0% | 100.0% | 100.0% | 10.4% | -4.6% | 3.3% | 0.0x | $141.8B | VS | |
$ASML ASML HOLDING NV | 77 | 89 | 86 | 83 | - | - | 46.1% | 16.6% | 51.3% | 31.9% | 26.8% | -4.0% | 1.0% | 25.0x | $272.1B | VS | |
$ESLT ELBIT SYSTEMS LTD | 76 | 81 | 87 | 85 | - | - | 10.3% | 3.1% | 24.1% | 7.2% | 4.7% | 14.3% | 0.8% | 25.0x | $11.4B | VS | |
$MT ArcelorMittal | 75 | 71 | 98 | 85 | - | - | 2.2% | 1.5% | 9.3% | 5.3% | 2.2% | -8.5% | 2.2% | 16.0x | $18.9B | VS | |
$AMAT APPLIED MATERIALS INC /DE | 75 | 85 | 87 | 84 | 20.9x | 13.6x | 35.5% | 19.8% | 48.7% | 29.2% | 24.7% | 4.4% | 0.8% | 32.0x | $181.9B | VS | |
$SIMO Silicon Motion Technology CORP | 75 | 84 | 86 | 85 | - | - | 11.8% | 8.8% | 45.9% | 11.3% | 11.1% | 25.7% | 3.7% | 0.0x | $1.8B | VS | |
$CODA Coda Octopus Group, Inc. | 74 | 83 | 90 | 79 | 16.3x | 11.9x | 7.6% | 7.0% | 66.5% | 17.1% | 15.6% | 39.0% | 0.0% | 0.0x | $115M | VS | |
$GSK GSK plc | 74 | 84 | 90 | 70 | - | - | 22.6% | 4.9% | 71.2% | 12.8% | 9.4% | 1.7% | 5.9% | 124.0x | $72.1B | VS | |
$EFXT Enerflex Ltd. | 74 | 80 | 91 | 83 | - | - | 3.0% | 1.1% | 20.9% | 7.3% | 1.3% | 3.0% | 0.9% | 67.0x | $1.2B | VS | |
$BUD Anheuser-Busch InBev SA/NV | 74 | 84 | 97 | 63 | - | - | 8.2% | 3.5% | 55.3% | 25.9% | 12.4% | 0.7% | 1.7% | 0.0x | $87.0B | VS | |
$CBT CABOT CORP | 63 | 83 | 94 | 41 | 9.4x | 6.3x | 24.3% | 11.2% | 25.6% | 16.9% | 11.2% | -16.7% | 2.3% | 117.0x | $4.0B | ||
| SECTOR BENCH | - | - | - | - | - | 22.3x | 11.5x | -2.5% | -0.1% | 42.5% | 1.3% | -0.2% | 5.9% | 0.0% | 0.2x | - | REF |
CABOT CORP (CBT) receives a "Hold" rating with a composite score of 62.8/100. It ranks #439 out of 7,333 stocks in our coverage universe and carries a 3-star rating. Ratings are driven by a 6-factor quantitative model measuring quality, value, momentum, investment, stability, and short interest.
Sign in to join the discussion.
YOY expansion rate
Core pricing power
Operating efficiency
Bottom-line conversion
Equity capital efficiency
Asset base utilization
Financial leverage load
Direct cash return
Sean D. Keohane
Chief Executive Officer
Labor Force
4,200
83
40
75
Audit Verdict: Average governance indicators based on financial metrics.
No recent insider transactions available for CBT
Headcount
4.2K
HQ Base
Boston, Massachusetts
In-line with peers — no strong momentum signal
Trading at a discount to fundamentals — favorable entry valuation
High profitability & efficiency — strong quality floor supports entry
Low volatility — smoother ride and historically better risk-adjusted returns
Moderate investment profile
Mid-range overall rating
Get full access to institutional-quality research tools with Blank Capital Pro.
Upgrade to ProStarting at $19.99/mo
Relative valuation derived from Manufacturing sector benchmarks. Model weights: EV/EBITDA (40%), P/B (35%), P/S (25%). Re-calculated daily.
Projection based on user-defined inputs. Re-calculated daily against current market data.
Reverse DCF Framework — Mauboussin Methodology
Institutional-grade Reverse DCF analysis. This model identifies the growth hurdles embedded in current market prices. When implied growth is significantly lower than historical or projected rates, a margin of safety may exist. Re-audited daily.
No analyst ratings for CBT.
View All RatingsMaterial decline in asset turnover efficiency detected
High margin volatility — erratic forensic earnings quality
| Factor | Global | Sector | Tilt |
|---|---|---|---|
| PROFITABILITY | 83 | 95 | -12DRAG |
| MOMENTUM | 41 | 23 | +18ALPHA |
| VALUATION | 94 | 97 | -3NEUTRAL |
| INVESTMENT | 40 | 73 | -33DRAG |
| STABILITY | 75 | 74 | +1NEUTRAL |
| SHORT INT | 31 | 18 | +13ALPHA |
Global = full universe. Sector = relative to industry peers. Positive tilt indicates idiosyncratic strength.
ROE proxy 24.3% (sector -2.5%)
GM 26% vs sector 43%, OM 17% vs sector 1%
Capital turnover N/A, R&D intensity 1.5%
Rev growth -17%, 11yr history
Interest coverage 7.2x
Composite assessment of profitability, capital efficiency, and financial strength. Top-tier entities demonstrate sustainable cash flow generation and elite competitive moats.
Profit generated per dollar of shareholder equity
Efficiency of asset utilization
Pricing power and cost efficiency
Core business profitability
Bottom-line profitability
The Quality factor evaluates the persistence and magnitude of realized cash flows. Companies with scores >70 exhibit superior pricing power and structural financial resilience through diverse economic regimes.
Our uncertainty rating tracks the predictability of future cash flows and potential for permanent capital loss. Moderate visibility with standard industry cyclicality.
Our model assigns CABOT CORP a Hold rating, with a composite score of 62.8/100 and 3 out of 5 stars. Ranked #439 of 7,333 stocks, CBT presents a mixed quantitative picture — neither compelling enough to initiate new positions nor weak enough to warrant selling. Investors already holding may consider maintaining their position while monitoring for changes in the factor profile.
CBT earns a quality score of 83/100, indicating above-average business quality. The company reports a return on equity of 24.3% (sector avg: -2.5%), gross margins of 25.6% (sector avg: 42.5%), net margins of 11.2% (sector avg: -0.2%). Companies in this tier generally demonstrate consistent profitability and efficient capital deployment, though they may face some competitive pressure.
From a valuation perspective, CBT scores an exceptional 94/100, indicating the stock trades at a deep discount relative to its fundamentals. Key valuation metrics include a P/E ratio of 9.40x, an EV/EBITDA of 6.27x, a P/B ratio of 2.28x. A value score this high suggests the market may be significantly underpricing the company's earnings power, assets, or cash flow generation.
With an investment score of 40/100, CBT exhibits moderate growth-oriented spending. Key growth metrics include revenue growth of -16.7% vs. a sector average of 5.9% and a return on assets of 11.2% (sector: -0.1%). The company appears to be balancing growth investments with capital returns, though the pace of investment may not be enough to accelerate top-line growth meaningfully.
CBT is currently showing below-average momentum at 41/100, which may indicate weakening institutional interest or negative sentiment shifts. Revenue growth stands at -16.7% year-over-year, while a beta of 0.78 reflects its sensitivity to broader market moves. Investors should note that declining momentum can precede further price weakness, though contrarian opportunities sometimes emerge at these levels.
CBT shows good financial stability with a score of 75/100. Key stability metrics include a beta of 0.78 and a debt-to-equity ratio of 117.00x (sector avg: 0.2x). This suggests manageable leverage and moderate price volatility, making it appropriate for investors seeking a balance between growth potential and capital preservation.
CABOT CORP's short interest score of 31/100 reveals significant bearish positioning, suggesting institutional investors are actively betting against the stock. Specific risk factors include elevated leverage (D/E: 117.00x). At $4.0B (mid-cap), CBT carries meaningful risk and is best suited for investors with high risk tolerance who have thoroughly evaluated the bear thesis.
CBT pays a solid dividend yield of 2.3%, contributing an income component to total returns. This moderate yield suggests a balance between returning capital to shareholders and retaining earnings for reinvestment — a common profile among quality compounders.
CABOT CORP is a mid-cap company in the Manufacturing sector, ranked #0 of 50 in its sector (100th percentile) and #439 of 7,333 overall (94th percentile). Key comparisons include ROE of 24.3% exceeding the -2.5% sector median and operating margins of 16.9% above the 1.3% sector average. This top-quartile standing reflects exceptional competitive strength relative to Manufacturing peers.
While CBT currently exhibits a HOLD profile, superior opportunities exist within the MANUFACTURING sector. Our model identifies several "Strong Buy" candidates with higher quality scores and more attractive valuations among direct industry competitors.
View Top Manufacturing Alpha →Quant Factor Profile
Key factor gap
Value (94) vs Short Int. (31) — closing this gap could shift the rating.
EV/EBITDA 45% BELOW SECTOR MEDIAN (FAVORABLE)
ROE 1079% BELOW SECTOR MEDIAN
Gross Margin 40% BELOW SECTOR MEDIAN
AUDIT DATA AS OF DEC 31, 2025 (Q3 FY2025)
We rate CABOT CORP (CBT) as a Hold with a composite score of 62.8/100 at a current price of $75.74. The stock presents a mixed quantitative picture — neither compelling enough to warrant new accumulation nor weak enough to justify selling for existing holders. Our factors are split, and the overall profile suggests patience is warranted.
The rating is primarily driven by strength in value (94th percentile) and quality (83th percentile), which together account for the majority of the composite score. All factors score above the 40th percentile, indicating no material weakness in the quantitative profile. We assign a Narrow Moat rating (49/100), Medium uncertainty, and Standard capital allocation.
Key items to watch: balance sheet deleveraging progress. Any material change in these dynamics could warrant a reassessment of our rating. The moat trend is stable, which suggests the competitive landscape is stable for now.
CABOT CORP holds a top-quartile position (#0 of 50) within the Manufacturing sector, based on our composite quantitative scoring across quality, value, momentum, and stability factors. The composite score of 62.8/100 places it at rank #439 in our full 7,333-stock universe. At $4.0B in market capitalization, CABOT CORP is a mid-cap player in the Manufacturing space, which limits certain scale advantages but may allow for more agile strategic execution.
Revenue contraction of -17% combined with momentum at the 41th percentile paints a cautious picture of the near-term business outlook. The market appears to be pricing in continued challenges, and a catalyst for reversal is not clearly visible from current data.
The margin cascade tells an important story: gross margins of 26% (-16.9pp vs sector) narrow to operating margins of 17% (+15.6pp vs sector) and net margins of 11.2%, yielding a gross-to-net conversion rate of 44%. This efficient conversion suggests well-controlled operating costs and limited margin leakage between the gross and net levels.
At a current price of $75.74, CABOT CORP appears undervalued relative to its fundamentals. Our value factor score of 94/100 reflects a composite assessment across multiple valuation metrics including price-to-earnings, price-to-book, EV/EBITDA, and price-to-sales ratios relative to both sector peers and the broader market. The stock screens as attractively priced on a majority of these measures, suggesting the market may be underappreciating the underlying fundamentals.
The stock currently trades at a P/E of 9.4x (a 58% discount to the sector median of 22.3x), EV/EBITDA of 6.3x (discounted to peers), P/B of 2.3x, P/S of 1.1x. The below-sector P/E suggests possible undervaluation or the market pricing in near-term headwinds.
Returns on equity of 24.3% exceed the cost of equity for most companies, indicating genuine shareholder value creation and a reinvestment engine that compounds wealth over time.
A value factor score of 94/100 suggests the market is underpricing these fundamentals, creating a potential margin of safety for new investors.
A 2.31% dividend yield provides income while you wait, and dividends historically account for a significant portion of total equity returns.
Return on assets of 11.2% indicates efficient deployment of the full asset base, not just equity capital.
Elevated leverage (117% D/E) amplifies downside risk and limits management's financial flexibility in adverse scenarios.
Revenue decline of -17% signals business deterioration — declining revenues make it difficult to grow into the current valuation and often precede further negative revisions.
We assign a Medium uncertainty rating to CABOT CORP. The stock presents a balanced risk profile: significant leverage (117% debt-to-equity). While not risk-free, the core business fundamentals are adequate to withstand moderate economic stress, and the range of potential outcomes around our fair value estimate is manageable.
Specific risk factors that inform our assessment include: significant leverage (117% debt-to-equity). Each of these factors independently widens the distribution of potential outcomes, and in combination they create a risk profile that demands careful position sizing. The stability factor at the 75th percentile and quality factor at the 83th percentile provide a quantitative summary of the overall risk landscape.
Key risk mitigants include: above-average stability (75th percentile) suggests predictable business dynamics; a 2.31% dividend yield anchors total return. These factors partially offset the identified risks and provide downside protection in adverse scenarios. On balance, the risk-reward profile is favorable for long-term investors.
We rate CABOT CORP's capital allocation as Standard. Management has shown adequate — though not exceptional — stewardship of shareholder capital. Returns on equity stand at 24.3%, and the balance sheet is managed within acceptable parameters (D/E: 117%). Exemplary allocators typically sustain ROE above 20% and D/E below 50%; CABOT CORP falls short on at least one dimension.
There is room for improvement in optimizing the capital structure or enhancing shareholder returns. The 2.31% dividend yield provides some income return, but the overall capital allocation framework would benefit from either higher reinvestment returns, improved balance sheet efficiency, or increased shareholder distributions. We will monitor for signs of strategic improvement that could warrant an upgrade.
In summary, CABOT CORP receives a Hold rating with a composite score of 62.8/100 (rank #439 of 7,333). Our quantitative framework assigns a Narrow Moat (49/100, trend: stable), Medium uncertainty, and Standard capital allocation. The average factor score across quality, value, momentum, stability, and investment is 67/100.
Our analysis supports a neutral stance on CABOT CORP. While the quantitative profile is not weak enough to warrant selling, it lacks the multi-factor strength required for a buy recommendation. Existing holders should maintain positions and monitor for catalysts — either fundamental improvement or valuation compression — that would shift the risk-reward balance.
Analysis derived from Blank Capital Research quantitative terminal. For informational purposes only. No trade solicitation. Past performance not indicative of future results. Consult a qualified advisor.
We assign CABOT CORP a Narrow Moat rating with a composite moat score of 49/100. The company possesses identifiable competitive advantages, though they are less entrenched than those of wide-moat peers. Our analysis indicates that CABOT CORP can sustain above-average returns on invested capital for at least 10 years, with the strongest contributor being financial resilience at 13.4/20.
The strongest moat sources are financial resilience (13.4/20) and margin superiority (12.7/20). Interest coverage 7.2x. GM 26% vs sector 43%, OM 17% vs sector 1%. These pillars form the core of CABOT CORP's competitive identity and are the primary drivers of excess returns in our framework.
Areas of relative weakness include reinvestment efficiency (0.5/20) and growth durability (10.8/20). Capital turnover N/A, R&D intensity 1.5%. Improvement in these areas could meaningfully widen the moat over time, while deterioration would be an early warning of competitive erosion.
Our moat trend assessment is Stable. Multi-year ROIC and operating margin trajectories show neither meaningful improvement nor deterioration, suggesting the competitive position is steady. We expect CABOT CORP's moat profile to remain largely unchanged absent a material shift in return on capital or industry dynamics.
Key profit drivers include operating margins of 17% reflecting effective cost management, declining revenues (-17%) that pressure the earnings outlook, returns on equity of 24.3% driving shareholder value creation. The margin cascade from 26% gross to 17% operating to 11.2% net reveals the company's cost structure and reinvestment intensity. Our analysis indicates that the profit engine is high-quality and likely sustainable, with the quality factor at the 83th percentile.
The margin profile shows gross margins of 26%, operating margins of 17%, net margins of 11.2%. Return metrics include ROE of 24.3% and ROA of 11.2%. Relative to the Manufacturing sector, gross margins are 16.9 percentage points below the sector median of 43%, and ROE of 24.3% compares to a sector median of -2.5%.
The balance sheet reflects above-average leverage with D/E of 117%, a dividend yield of 2.31%, revenue growth of -17%. The sector median D/E is 0%, putting CABOT CORP at higher leverage than the typical peer. Overall balance sheet health is adequate for the current business environment.
Above 50MA
37.18%
Net New Highs
+51081
Cabot Corporation recently reported fiscal first-quarter 2026 results showing lower sales of US$849 million and net income of US$73 million year on year, while still delivering adjusted earnings per share ahead of analyst expectations. At the same time, Cabot advanced its portfolio by securing a multi-year conductive carbons supply deal with PowerCo SE, completing the Mexico Carbon Manufacturing acquisition, continuing share repurchases, and affirming a US$0.45 quarterly dividend,...
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Cabot (CTRA), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
In February 2026, Cabot Corporation confirmed that its plants in Cilegon, Indonesia and Tianjin, China can now produce circular reinforcing carbons using tire pyrolysis oil under the ISCC PLUS mass-balance framework, extending coverage of its EVOLVE Sustainable Solutions platform across Asia Pacific. This expansion gives Cabot circular reinforcing carbon production in all major regions, aligning closely with tire makers’ long-term sustainability targets while supporting a “make-in-region,...
Cabot Corporation (NYSE:CBT) is among the 9 Undervalued Chemical Stocks to Buy According to Hedge Funds. Cabot Corporation (NYSE:CBT) is among the best chemical stocks. TheFly reported on February 5 that UBS raised CBT’s price target to $81 from $74 and gave it a Neutral rating. In a major developmental news, on February 18, Cabot […]
Company now has capabilities across key regions to advance sustainable offerings BOSTON, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Cabot Corporation (NYSE: CBT) today announced the availability to produce in Asia Pacific its circular reinforcing carbons powered by its EVOLVE Sustainable Solutions technology platform. As such, Cabot's manufacturing facilities in Cilegon, Indonesia and Tianjin, China have successfully validated their ability to produce circular reinforcing carbons. These products use tire